TargetMol

LY 81067

Product Code:
 
TAR-T25764
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T25764-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25764-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25764-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
LY 81067 is a new anticonvulsive compound.
CAS:
87186-60-5
Formula:
C22H24N4O
Molecular Weight:
360.461
Purity:
0.98
SMILES:
Cc1ccc(cc1)-c1nnc(nc1-c1ccc(C)cc1)N1CCC(O)CC1

References

1. Wong DT, Threlkeld PG, Bymaster FP, Squires RF. Saturable binding of 35S-t-butylbicyclophosphorothionate to the sites linked to the GABA receptor and the interaction with GABAergic agents. Life Sci. 1984 Feb 27;34(9):853-60. PubMed PMID: 6321873. 2. Wong DT, Rathbun RC, Bymaster FP, Lacefield WB. Enhanced binding of radioligands to receptors of gamma-aminobutyric acid and benzodiazepine by a new anticonvulsive agent, LY81067. Life Sci. 1983 Sep 5;33(10):917-23. PubMed PMID: 6310287. 3. Brouillet E, Chavoix C, de la Sayette V, Hantraye P, Kunimoto M, Khalili-Varasteh M, Guibert B, Fournier D, Dodd RH, Naquet R, et al. Anticonvulsant activity of the diaryltriazine, LY81067: studies using electroencephalographic recording and positron emission tomography. Neuropharmacology. 1989 Apr;28(4):351-8. PubMed PMID: 2501707.